Ally Bridge Group (Ny) LLC Cogent Biosciences, Inc. Transaction History

Ally Bridge Group (Ny) LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.39 - $16.99 $6.13 Million - $11.1 Million	-653,338 Reduced 76.2%	204,014 $3.04 Million
Q2 2022 Aug 15, 2022	SELL	$3.92 - $9.73 $1.77 Million - $4.4 Million	-452,078 Reduced 34.52%	857,352 $7.73 Million
Q1 2022 May 16, 2022	SELL	$5.31 - $8.7 $1.02 Million - $1.67 Million	-192,161 Reduced 12.8%	1,309,430 $9.81 Million
Q4 2021 Feb 14, 2022	SELL	$7.51 - $10.81 $908,710 - $1.31 Million	-121,000 Reduced 7.46%	1,501,591 $12.9 Million
Q4 2020 Feb 16, 2021	BUY	$9.04 - $13.01 $14.7 Million - $21.1 Million	1,622,591 New	1,622,591 $18.2 Million

172

114M

56.7K

40.4K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $612M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.